Skip to main content
. 2021 Jun 30;13(13):3278. doi: 10.3390/cancers13133278
ADT androgen deprivation therapy
ChIP-seq chromatin immunoprecipitation sequencing
CT computed tomography
cfDNA circulating cell-free DNA
ctDNA circulating tumor DNA
CTC circulating tumor cell
EGFR epidermal growth factor receptor
EMT epithelial mesenchymal transition
EpCAM epithelial cellular adhesion molecule
hTERT telomerase reverse transcriptase
miRNA micro Ribo-Nucleic Acid
MDT metastases directed treatment
NGS nextgeneration sequencing
OCS-PCa oligorecurrent-castration-sensitive-PCa
OMPC oligometastatic prostate cancer
PCa prostate cancer
PCR polymerase chain reaction
PET positron emission tomography
PMPC polymetastatic prostate cancer
PSA prostate-specific antigen
PSMA prostate-specific membrane antigen
RISC RNA-induced silencing complex
SBRT stereotactic body radiotherapy
SNP single nucleotide polymorphism
WB-MRI whole-body magnetic resonance imaging